Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 766101 | ISIN: US6294452064 | Ticker-Symbol: NVK
Frankfurt
26.04.24
21:41 Uhr
74,50 Euro
+1,00
+1,36 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NVE CORPORATION Chart 1 Jahr
5-Tage-Chart
NVE CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
74,5076,0013:04
74,5076,0026.04.
GlobeNewswire (Europe)
404 Leser
Artikel bewerten:
(2)

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend

EDEN PRAIRIE, Minn., Jan. 17, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and nine months ended December 31, 2023.

Total revenue for the third quarter of fiscal 2024 decreased 9% to $6.76 million from $7.40 million for the prior-year quarter. The decrease was due to a 12% decrease in product sales, partially offset by a 94% increase in contract research and development revenue. Net income for the third quarter of fiscal 2024 decreased 1% to $4.18 million, or $0.87 per diluted share, compared to $4.23 million, or $0.88 per share, for the prior-year quarter.

For the first nine months of fiscal 2024, total revenue decreased 11% to $22.7 million from $25.5 million for the first nine months of the prior year. The decrease was due to an 11% decrease in product sales and a 20% decrease in contract research and development revenue. Net income decreased 8% to $13.3 million, or $2.75 per diluted share, from $14.5 million, or $2.99 per share, for the first nine months of fiscal 2023.

The company also announced a quarterly cash dividend to shareholders of $1.00 per share of common stock, payable February 28, 2024, to shareholders of record as of January 29, 2024.

"We are pleased to report solid earnings for the quarter and nine months despite a decrease in defense-related product sales and a semiconductor industry downturn," said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D.

NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.

Statements used in this press release that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as our reliance on several large customers for a significant percentage of revenue, uncertainties related to the economic environments in the industries we serve, uncertainties related to future sales and revenues, risks of credit losses, risks and uncertainties related to future dividend payments, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2023, as updated in our Quarterly Reports on Form 10-Q for the quarters ended December 31 and June 30, 2023.

###

NVE CORPORATION
STATEMENTS OF INCOME
QUARTERS AND NINE MONTHS ENDED DECEMBER 31, 2023 AND 2022
(Unaudited)
Quarter Ended December 31,
2023 2022
Revenue
Product sales $6,366,009 $7,200,385
Contract research and development 390,251 201,293
Total revenue 6,756,260 7,401,678
Cost of sales 1,355,067 1,478,372
Gross profit 5,401,193 5,923,306
Expenses
Research and development 540,895 700,609
Selling, general, and administrative 389,311 403,449
Total expenses 930,206 1,104,058
Income from operations 4,470,987 4,819,248
Interest income 491,671 406,092
Income before taxes 4,962,658 5,225,340
Provision for income taxes 778,236 994,016
Net income $4,184,422 $4,231,324
Net income per share - basic $0.87 $0.88
Net income per share - diluted $0.87 $0.88
Cash dividends declared per common share $1.00 $1.00
Weighted average shares outstanding
Basic 4,833,401 4,830,826
Diluted 4,837,230 4,832,368


Nine Months Ended Dec. 31,
2023 2022
Revenue
Product sales $22,183,223 $24,787,885
Contract research and development 537,727 668,024
Total revenue 22,720,950 25,455,909
Cost of sales 5,034,556 5,533,000
Gross profit 17,686,394 19,922,909
Expenses
Research and development 1,920,095 1,972,505
Selling, general, and administrative 1,298,211 1,210,395
Provision for credit losses 9,514 -
Total expenses 3,227,820 3,182,900
Income from operations 14,458,574 16,740,009
Interest income 1,440,289 1,040,528
Income before taxes 15,898,863 17,780,537
Provision for income taxes 2,587,145 3,318,723
Net income $13,311,718 $14,461,814
Net income per share - basic $2.75 $2.99
Net income per share - diluted $2.75 $2.99
Cash dividends declared per common share $3.00 $3.00
Weighted average shares outstanding
Basic 4,832,992 4,830,826
Diluted 4,839,725 4,831,168

NVE CORPORATION
BALANCE SHEETS
DECEMBER 31 AND MARCH 31, 2023
(Unaudited)
Dec. 31,
2023
March 31,
2023
ASSETS
Current assets
Cash and cash equivalents $4,684,910 $1,669,896
Marketable securities, short-term (amortized cost of $14,556,450
as of December 31, 2023, and $15,696,135 as of March 31, 2023)
14,335,619 15,513,095
Accounts receivable, net of allowance for credit losses of $15,000 2,245,728 6,523,344
Inventories 7,349,811 6,417,010
Prepaid expenses and other assets 597,305 663,459
Total current assets 29,213,373 30,786,804
Fixed assets
Machinery and equipment 10,501,096 10,484,365
Leasehold improvements 1,956,309 1,956,309
12,457,405 12,440,674
Less accumulated depreciation and amortization 11,326,985 11,095,236
Net fixed assets 1,130,420 1,345,438
Deferred tax assets 1,290,284 572,038
Marketable securities, long-term (amortized cost of $36,414,391
as of December 31, 2023, and $37,495,846 as of March 31, 2023)
35,670,914 36,125,047
Right-of-use asset - operating lease 324,451 425,843
Total assets $67,629,442 $69,255,170
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Accounts payable $170,701 $281,712
Accrued payroll and other 460,414 1,375,250
Operating lease 178,490 175,798
Total current liabilities 809,605 1,832,760
Operating lease 218,785 342,908
Total liabilities 1,028,390 2,175,668
Shareholders' equity
Common stock, $0.01 par value, 6,000,000 shares authorized; 4,833,401 issued and outstanding as of December 31, 2023, and 4,830,826 as of March 31, 2023 48,334 48,308
Additional paid-in capital 19,542,335 19,295,442
Accumulated other comprehensive loss (753,317) (1,213,858)
Retained earnings 47,763,700 48,949,610
Total shareholders' equity 66,601,052 67,079,502
Total liabilities and shareholders' equity $67,629,442 $69,255,170
 
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.